Hitachi-Thales Deal Won't Hurt Competition in Urban Signalling Systems, UK Regulator Says
By Maitane Sardon
The U.K.'s competition watchdog said Wednesday that Hitachi Rail's proposed acquisition of Thales's transportation-systems business won't reduce competition in the supply of communications-based train control signalling systems in the U.K.
The Competition and Markets Authority said that it has found new evidence that supports the conclusion that Hitachi won't be a credible bidder to supply communications-based train control, or CBTC, signalling systems to the London Underground in the near to medium term as it had found initially.
It said that the update doesn't change its provisional assessment that the merger is likely to lead to a "substantial lessening of competition" regarding the supply of digital mainline signalling.
Thales and Hitachi Rail entered into negotiations for the sale of the ground transportation systems business in August 2021 for an enterprise value of 1.66 billion euros ($1.80 billion). Thales said it aims to close the acquisition within the second half of 2023.
Write to Maitane Sardon at maitane.sardon@wsj.com
(END) Dow Jones Newswires
August 23, 2023 03:48 ET (07:48 GMT)
Copyright (c) 2023 Dow Jones & Company, Inc.-
5 Undervalued Stocks to Buy to Play a Little Defense
-
Markets Brief: AI Leaders Excel In Earnings Season So Far
-
What History Tells Us About the Fed’s Next Move
-
What’s Happening In the Markets This Week
-
Alphabet’s New Dividend: What Investors Need to Know
-
Going Into Earnings, Is Palantir Stock a Buy, a Sell, or Fairly Valued?
-
Going Into Earnings, Is Eli Lilly Stock a Buy, a Sell, or Fairly Valued?
-
What’s the Difference Between the CPI and PCE Indexes?
-
After Earnings, Is Tesla Stock a Buy, a Sell, or Fairly Valued?
-
After Earnings, Is GE Aerospace Stock a Buy, a Sell, or Fairly Valued?
-
3 Good Stocks to Buy with Your Tax Refund in 2024 (Or with Any Extra Money)
-
SoFi Earnings: Revenue Growth Slows on Lower Loan Growth and Higher Credit Costs
-
Tesla: Full Self-Driving Approval In China Supports Our View for Deliveries Growth In 2024
-
Philips Earnings: Firm Reaches $1.1 Billion Settlement Agreement
-
AbbVie Earnings: Next-Generation Immunology Drugs Help Offset Humira Biosimilar Pressure
-
Exxon Earnings: Ignore Earnings Shortfall as Long-Term Growth and Improvement on Track